Page 91 - JCTR-11-5
P. 91
Journal of Clinical and
Translational Research ROCK inhibition in chronic rejection
A B
C
D
E
Figure 3. Comparison of downregulated genes between Rezurock/fingolimod combination treatment and Rezurock-only treatment in mouse macrophages.
(A and B) Venn diagrams showing the overlap of downregulated genes in Rezurock/fingolimod combination treatment and Rezurock-only treatment.
(C) GO analysis of downregulated genes specific to the Rezurock/fingolimod combination treatment. (D) GO analysis of downregulated genes specific to
the Rezurock-only treatment. (E) GO analysis of downregulated genes common to both Rezurock/fingolimod combination and Rezurock-only treatments.
Abbreviations: GO: Gene ontology; ECM: Extracellular matrix; NTR: Non-catalytic tyrosine-phosphorylated receptor; TP53: Tumor protein 53.
Volume 11 Issue 5 (2025) 85 doi: 10.36922/JCTR025270036

